This company has been marked as potentially delisted and may not be actively trading. Vaccitech (VACC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesInsider TradesTrendsBuy This Stock VACC vs. PROC, OPTN, WHWK, VIRI, PYRGF, VHAQ, ATNM, AADI, EGRX, and OSTXShould you be buying Vaccitech stock or one of its competitors? The main competitors of Vaccitech include Procaps Group (PROC), OptiNose (OPTN), Whitehawk Therapeutics (WHWK), Virios Therapeutics (VIRI), PyroGenesis Canada (PYRGF), Viveon Health Acquisition (VHAQ), Actinium Pharmaceuticals (ATNM), Aadi Bioscience (AADI), Eagle Pharmaceuticals (EGRX), and OS Therapies (OSTX). Vaccitech vs. Its Competitors Procaps Group OptiNose Whitehawk Therapeutics Virios Therapeutics PyroGenesis Canada Viveon Health Acquisition Actinium Pharmaceuticals Aadi Bioscience Eagle Pharmaceuticals OS Therapies Vaccitech (NASDAQ:VACC) and Procaps Group (NASDAQ:PROC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership. Which has stronger earnings & valuation, VACC or PROC? Procaps Group has higher revenue and earnings than Vaccitech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccitech$13.42M2.87$5.34M-$1.43-0.70Procaps Group$409.92M0.26$42.54MN/AN/A Does the media refer more to VACC or PROC? In the previous week, Vaccitech's average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score. Company Overall Sentiment Vaccitech Neutral Procaps Group Neutral Do insiders & institutionals have more ownership in VACC or PROC? 26.1% of Vaccitech shares are held by institutional investors. 6.0% of Vaccitech shares are held by company insiders. Comparatively, 19.9% of Procaps Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, VACC or PROC? Vaccitech has a beta of -0.4, indicating that its stock price is 140% less volatile than the S&P 500. Comparatively, Procaps Group has a beta of -0.05, indicating that its stock price is 105% less volatile than the S&P 500. Is VACC or PROC more profitable? Procaps Group has a net margin of 0.00% compared to Vaccitech's net margin of -409.18%. Procaps Group's return on equity of 0.00% beat Vaccitech's return on equity.Company Net Margins Return on Equity Return on Assets Vaccitech-409.18% -23.41% -20.85% Procaps Group N/A N/A N/A SummaryProcaps Group beats Vaccitech on 7 of the 9 factors compared between the two stocks. Get Vaccitech News Delivered to You Automatically Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VACC vs. The Competition Export to ExcelMetricVaccitechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.55M$881.03M$5.62B$9.10BDividend YieldN/A4.84%5.24%4.00%P/E Ratio-0.701.3828.0520.27Price / Sales2.87241.37429.5999.27Price / Cash19.3017.6937.4658.16Price / Book0.156.588.055.49Net Income$5.34M-$23.83M$3.18B$250.45M Vaccitech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VACCVaccitechN/A$1.00-5.7%N/A-26.1%$38.55M$13.42M-0.7033Gap DownPROCProcaps GroupN/A$0.95-40.3%N/A-62.2%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeOPTNOptiNose0.6578 of 5 stars$9.60flat$9.00-6.3%N/A$97.22M$81.86M-2.29190WHWKWhitehawk TherapeuticsN/A$2.01+1.0%N/AN/A$93.75M$25.98M0.0040High Trading VolumeVIRIVirios TherapeuticsN/A$4.84+5.2%$5.00+3.3%+1,936.7%$93.21MN/A-17.935Gap DownPYRGFPyroGenesis Canada0.0929 of 5 stars$0.35+1.2%N/A-55.0%$64.48M$9.14M-5.8390News CoverageVHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumeATNMActinium Pharmaceuticals2.8264 of 5 stars$1.58+10.5%$4.00+153.2%N/A$49.29MN/A-1.1430News CoveragePositive NewsAADIAadi Bioscience0.4713 of 5 stars$1.99+0.5%$1.67-16.2%+31.3%$49.15M$25.07M-0.8740EGRXEagle Pharmaceuticals2.4566 of 5 stars$3.65+12.3%N/A-41.1%$47.40M$257.55M0.00100News CoverageGap DownOSTXOS Therapies1.7181 of 5 stars$1.66+2.5%$18.00+984.3%N/A$46.64MN/A-1.93N/ANews Coverage Related Companies and Tools Related Companies Procaps Group Competitors OptiNose Competitors Whitehawk Therapeutics Competitors Virios Therapeutics Competitors PyroGenesis Canada Competitors Viveon Health Acquisition Competitors Actinium Pharmaceuticals Competitors Aadi Bioscience Competitors Eagle Pharmaceuticals Competitors OS Therapies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VACC) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccitech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccitech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VACC Stock Alerts